Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -236.86x is 255% below its 5-year average of -66.68x, near the high end of its 5-year range (-59871.29x–-6.14x).
32.61% above its 12-month average of -351.47x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2025 (2025-09-30): -65.55x.
INTEREST COVERAGE RATIO
-236.86x
INTEREST COVERAGE RATIO AVG TTM
-351.47x
INTEREST COVERAGE RATIO AVG 3Y
-8711.00x
INTEREST COVERAGE RATIO AVG 5Y
-66.68x
INTEREST COVERAGE RATIO AVG 10Y
-28.33x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+32.61%
CURRENT VS 3Y AVG
+97.28%
CURRENT VS 5Y AVG
-255.21%
CURRENT VS 10Y AVG
-736.13%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-3577.95%
vs the sector median at left
Outlook Therapeutics, Inc.
Market Cap
$106.96M
Interest Coverage Ratio
-236.86x
TTM Avg
-351.47x
3Y Avg
-8711.00x
5Y Avg
-66.68x
Market Cap
$106.98M
Interest Coverage Ratio
-5.63x
TTM Avg
53.06x
3Y Avg
67.81x
5Y Avg
43.09x
Market Cap
$106.93M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$107.09M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$107.17M
Interest Coverage Ratio
-1.15x
TTM Avg
4.51x
3Y Avg
6.93x
5Y Avg
222.11x
Market Cap
$109.14M
Interest Coverage Ratio
-280.53x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.68M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.26M
Interest Coverage Ratio
-1.82x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | $106.96M | -236.86x | -351.47x | -8711.00x | -66.68x |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.98M | -5.63x | 53.06x | 67.81x | 43.09x |
| Vivani Medical, Inc. (VANI)vs › | $106.93M | N/A | N/A | N/A | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.09M | N/A | N/A | N/A | N/A |
| Apyx Medical Corporation (APYX)vs › | $107.17M | -1.15x | 4.51x | 6.93x | 222.11x |
| Immunic, Inc. (IMUX)vs › | $106.52M | N/A | N/A | N/A | N/A |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $109.14M | -280.53x | N/A | N/A | N/A |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | N/A | N/A | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | -1.82x | N/A | N/A | N/A |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $110.30M | N/A | N/A | N/A | N/A |
Interest Coverage
-236.9x
Debt/Equity
N/A
Current Ratio
0.81
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-09-30 | -65.55x |
| 2025-06-30 | -319.12x |
| 2025-03-31 | -669.74x |
| 2024-03-31 | -6.14x |
| 2023-06-30 | -59871.29x |
| 2022-12-31 | -6.41x |
| 2022-09-30 | -38.78x |
| 2022-06-30 | -47.69x |
| 2022-03-31 | -45.20x |
| 2021-12-31 | -37.41x |
| 2021-09-30 | -49.91x |
| 2021-06-30 | -44.67x |
| 2021-03-31 | -50.42x |
| 2020-12-31 | -88.88x |
| 2020-09-30 | -526.18x |
| 2020-06-30 | -24.64x |
| 2020-03-31 | -8.87x |
| 2019-12-31 | -13.69x |
| 2019-09-30 | -60.39x |
| 2019-06-30 | -5.22x |
| 2019-03-31 | -7.31x |
| 2018-12-31 | -9.15x |
| 2018-09-30 | -11.23x |
| 2018-06-30 | -6.29x |
| 2018-03-31 | -7.42x |
| 2017-12-31 | -4.43x |
| 2017-09-30 | -1.06x |
| 2017-06-30 | -4.20x |
| 2017-03-31 | -6.30x |
| 2016-12-31 | -36.38x |
| 2016-09-30 | -44.75x |
| 2016-06-30 | -73.56x |
| 2016-03-31 | -5.49x |
| 2015-12-31 | -41.14x |
| 2015-09-30 | -25.58x |
| 2015-06-30 | -19.91x |
| 2015-03-31 | -19.83x |
| 2014-12-31 | -11.59x |
